Trials / Completed
CompletedNCT01596842
Effect of Omega-3 Fatty Acid on Vitamin D Activation
Effect of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Dong-A University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Extra-renal sources of 1, 25-dihydroxyvitamin D can be increased to normal serum 1, 25-dihydroxyvitamin D levels in chronic kidney disease patients after administration of high dose 25-hydroxyvitamin D. The investigators observed that 1, 25-dihydroxyvitamin D concentrations were significantly increased after 3 months of omega-3 FA supplementation compared to baseline levels without 25-hydroxyvitamin D administration in dialysis patients. In this study, the investigators hypothesized that omega-3 FA and 25-hydroxyvitamin D supplementations may increase 1, 25-dihydroxyvitamin D concentrations much more compared to 25-hydroxyvitamin D supplementation only in hemodialysis patients with insufficient or deficient 25-hydroxyvitamin D levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omega-3 fatty acid ethylester 90 | Omega-3 fatty acid ethylester 90, Dosage form :1g soft capsule, Dosage : one capsule, thrice a day, Duration : 12 weeks |
| OTHER | Olive oil | Olive oil, Dosage form :1g soft capsule, Dosage : one capsule, thrice a day, Duration : 12 weeks |
| OTHER | cholecalciferol | if baseline 25-hydroxyvitamin D levels are \< 15 ng/mL : 10,000IU/week, if baseline 25-hydroxyvitamin D levels are 16-30 ng/mL : 50,000IU/week, Duration : 12 weeks |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2012-05-11
- Last updated
- 2015-03-10
- Results posted
- 2015-03-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01596842. Inclusion in this directory is not an endorsement.